CN104435567A - Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout - Google Patents
Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout Download PDFInfo
- Publication number
- CN104435567A CN104435567A CN201410626212.0A CN201410626212A CN104435567A CN 104435567 A CN104435567 A CN 104435567A CN 201410626212 A CN201410626212 A CN 201410626212A CN 104435567 A CN104435567 A CN 104435567A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- gout
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
The invention relates to a traditional Chinese medicinal composition, particularly relates to a tradtional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout and belongs to the technical field of medicine. The traditional Chinese medicinal composition for treating gout is a medicament prepared from the following medicinal raw materials in parts by weight: 15-35 parts of perilla, 3-15 parts of root of red-rooted salvia, 2-8 parts of gynostemma pentaphyllum, 3-8 parts of rhizoma tupistrae chinensis, 3-8 parts of common clubmoss herb and 1-5 parts of licorice. The traditional Chinese medicinal composition for treating gout, prepared by combining six medicinal raw materials according to a proportion, has a synergistic function and a significant treatment effect of treating gout, and does not have obvious side effect or adverse response.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Chinese medicine composition of the treatment gout containing Herb Gynostemmae Pentaphylli, belong to medical art.
Background technology
Gout is also known as hyperuricemia, and sickness rate is high, healing is difficult, recurrent exerbation, belongs to the metabolic disease that disorders of purine metabolism causes.Gout is multiple is born in middle-aged and elderly people, overweight people and brain worker, the gouty acute arthritis recurrent exerbation that its clinical characters is hyperuricemia and causes thus, tophaceous deposition, tophaceous chronic arthritis and joint deformity etc., dumb for main clinical manifestation with redness and swelling of joints, burning pain, recurrent exerbation, joint motion.Often involving kidney causes chronic interstitial nephritis and uric acid kidney stones to be formed.Increase reason according to uric acid in blood and can be divided into constitutional and the large class of Secondary cases two.The cause of disease of primary gout is caused by congenital purine metabolic disturbance, belongs to heritability.The cause of disease of secondary gout, can be caused by many reasons such as nephropathy, leukemia, medicine, foods, be apt to occur in male and menopausal woman.
The Western medicine being used for the treatment of gout at present mainly contains: colchicine, Phenylbutazone or crovaril, indometacin, ibuprofen (ibvprofen, ibuprofen), piroxicam (piroxicanum), naproxen (naproxen congex), ACTH and prednisone etc.But said medicine can only stablize the state of an illness mostly, gout can not be effected a radical cure; Serious side effect also can be caused to cause the infringement of hepatic and renal function; Even if Emergent therapy effectively can not recur by symptom management, and drug resistance and repellence can be produced, even there will be leukopenia, cardiac function is impaired, hepatic and renal function is impaired, stimulating intestine and stomach system, aplastic anemia, cause the complication such as diabetes.
In Chinese medicine, gout belongs to " arthromyodynia " category, " treatise on blood trouble ": " gout, general numbness and hypoesthesia, limbs pain, modern name gout, Gu say arthromyodynia ".Increasing expert thinks, from the organic conception of the traditional Chinese medical science, treats with Chinese medicine integral syndrome differentiation, the good footpath of another bar for the treatment of gout of can yet be regarded as; Not only the toxic and side effects of Chinese medicine itself is little, and can reduce Western medicine dose, overcomes the huge toxic and side effects taken merely Western medicine for a long time and bring.
Summary of the invention
To the object of the invention is to overcome in prior art existing Western medicine side effect large, treat halfway above-mentioned deficiency, a kind of Chinese medicine composition of the treatment gout containing Herb Gynostemmae Pentaphylli is provided, this traditional Chinese medicine composition for treating gout good effect, instant effect, and little to patient body side effect.
In order to realize foregoing invention object, the invention provides following technical scheme:
Containing a Chinese medicine composition for the treatment gout of Herb Gynostemmae Pentaphylli, it is prepared from by the medicinal raw material of following weight proportion: Folium Perillae 15 ~ 35 parts, Radix Salviae Miltiorrhizae 3 ~ 15 parts, Herb Gynostemmae Pentaphylli 2 ~ 8 parts, Rhizoma Tupistrae Chinensis 3 ~ 8 parts, Herba Lycopodii 3 ~ 8 parts, 1 ~ 5 part, Radix Glycyrrhizae.Described various medicinal raw material is the Chinese crude drug meeting country or provincial standard and specify.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Folium Perillae is 20 ~ 30 parts.Preferred, part by weight shared by Folium Perillae is 25 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Radix Salviae Miltiorrhizae is 5 ~ 10 parts.Preferred, part by weight shared by Radix Salviae Miltiorrhizae is 8 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Herb Gynostemmae Pentaphylli is 4 ~ 7 parts.Preferred, part by weight shared by Herb Gynostemmae Pentaphylli is 5 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Rhizoma Tupistrae Chinensis is 5 ~ 7 parts.Preferred, part by weight shared by Rhizoma Tupistrae Chinensis is 6 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Herba Lycopodii is 5 ~ 7 parts.Preferred, part by weight shared by Herba Lycopodii is 6 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Radix Glycyrrhizae is 2 ~ 4 parts.Preferred, part by weight shared by Radix Glycyrrhizae is 3 parts.
The Chinese medicine composition for the treatment of gout of the present invention, the active component of medicinal raw material can be extracted according to extracting method conventional on Chinese materia medica, add pharmaceutically acceptable carrier or/and adjuvant, as starch, dextrin, microcrystalline cellulose, amylum pregelatinisatum, magnesium stearate, micropowder silica gel, sucrose, carboxymethyl starch sodium, hydroxypropyl emthylcellulose, vegetable oil, lecithin, Polyethylene Glycol, propylene glycol, ethyl hydroxybenzoate etc., make dosage form suitable on pharmaceutics, as granule, tablet, hard capsule, oral liquid, soft capsule, drop pill, water pill etc.
The extracting method of Chinese medicine composition of the present invention can adopt but be not limited to following methods:
(1) get each medicinal raw material by formula proportion, in medicinal raw material, add 60 ~ 80% ethanol or the water of medicinal raw material volume 8 ~ 10 times; Reflux, extract, 2 ~ 3 times; Extraction time is respectively 1 ~ 2h; Collect merge extractive liquid, and extracting solution is condensed into extractum, dry, obtain the extract of medicinal raw material of the present invention.
(2) in above-mentioned extract, add pharmaceutic adjuvant and be mixed and made into acceptable various pharmaceutical dosage form on pharmaceutics.
According to the needs of the various drug form of preparation, medicine of the present invention also can add suitable pharmaceutic adjuvant as filler, disintegrating agent, binding agent, lubricant, antiseptic etc. in preparation process.
Compared with prior art, beneficial effect of the present invention:
The present invention treats the Chinese medicine composition of gout, be inventor based on the pathogenetic understanding of motherland's medical science to gout, according to oneself clinical experience for many years, first from numerous Chinese medicine, determine the effective Chinese medicine of a series for the treatment of gouts, repeatedly verify through clinical again, screen.Wherein, Folium Perillae, calls red Soviet Union, red Soviet Union, purple Soviet Union, wrinkle Folium Perillae; For the band branch tender leaf of Labiatae Perilla plant Folium Perillae; Pungent, warm; Enter spleen, lung meridian; There is effect of expelling cold and relieving exterior syndrome, regulating the flow of QI to ease the stomach; For diseases such as anemofrigid cold, headache, cough, distension and fullness of the chest and abdomen.Radix Salviae Miltiorrhizae, another name Arisaema balansae Engl., Radix Campylotropis Hirtella (Herba Myrsines Africanae), Herba Wedeliae Wallichii root, blood mountain root, RADIX SALVIAE MILTIORRHIZAE, Radix Salviae Miltiorrhizae; For the dry root and rhizome of labiate Radix Salviae Miltiorrhizae.Hardship, is slightly cold; GUIXIN, Liver Channel; There is effect of stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the relieving restlessness that clears away heart-fire; Swell and ache for menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection, dysphoria and insomnia, hepatosplenomegaly, the disease such as angina pectoris.Herb Gynostemmae Pentaphylli, another name Herba Gynostemmatis, Herba Gynostemmatis, Herb Gynostemmae Pentaphylli.Hardship, cold; Return lung, spleen, kidney channel; There is effect of heat-clearing and toxic substances removing, eliminating phlegm and stopping cough; For chronic bronchitis, infectious hepatitis, nephritis, gastroenteritis.Rhizoma Tupistrae Chinensis is the rhizome of liliaceous plant Rhizoma Tupistrae Chinensis; Sweet and slightly bitter taste, cold in nature, there is effect of nourishing yin and purging fire, promoting blood flow to regulate menstruation; For controlling the diseases such as consumptive fever cough, rheumatic arthralgia, menoxenia, traumatic injury.Herba Lycopodii, calls Lycopodium clavatum, lion tail, lion grass, green hair stretches muscle etc., is the dry herb of lycopsid Lycopodium clavatum; Mildly bitter flavor, pungent, warm in nature; Return liver,spleen,kidney warp.There is effect of expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral; For joint aches, the diseases such as joint stuffiness.Radix Glycyrrhizae is the dry root of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L.; Sweet in the mouth, property is put down; GUIXIN, lung, spleen, stomach warp; There is effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription; For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious disease such as pain, carbuncle sore tumefacting virus of extremity contraction.Above-mentioned 6 taste Chinese herbal medicine, flavour of a drug are few but function is complete, 6 taste medicinal raw materials are by after described proportioning combination, treatment gout has Synergistic function, and through clinical research test, Chinese medicine composition of the present invention is used for the treatment of gout short treating period, instant effect, administration is after 4 days, can take effect, and evident in efficacy, there is not obvious adverse reaction during patient consumes.
Detailed description of the invention
Below in conjunction with test example and detailed description of the invention, the present invention is described in further detail, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following embodiment, and all technology realized based on content of the present invention all belong to scope of the present invention.
In embodiments of the invention and comparative example, ethanol used is the aqueous solution of ethanol, and the percentage composition of ethanol, if no special instructions, is volumn concentration.
Embodiment 1
The Chinese medicine composition of the treatment gout of the present embodiment is be prepared from by the medicinal raw material of following weight proportion: Folium Perillae 25g, Radix Salviae Miltiorrhizae 8g, Herb Gynostemmae Pentaphylli 5g, Rhizoma Tupistrae Chinensis 6g, Herba Lycopodii 6g, Radix Glycyrrhizae 3g.
The extracting method of above-mentioned medicinal raw material:
(1) get each medicinal raw material by formula proportion, in medicinal raw material, add 60 ~ 80% ethanol or the water of medicinal raw material volume 8 ~ 10 times; Reflux, extract, 2 ~ 3 times; Extraction time is respectively 1 ~ 2h; Collect merge extractive liquid, and extracting solution is concentrated into relative density 1.20 (80 DEG C), obtain the extract of embodiment 1 medicinal raw material.
(2) in above-mentioned extract, add the soluble starch of extract weight 2 times of weight, granulate, dry, be distributed into bag, obtain granule.
Embodiment 2
The Chinese medicine composition of the treatment gout of the present embodiment is be prepared from by the medicinal raw material of following weight proportion: Folium Perillae 35g, Radix Salviae Miltiorrhizae 13g, Herb Gynostemmae Pentaphylli 2g, Rhizoma Tupistrae Chinensis 7g, Herba Lycopodii 3g, Radix Glycyrrhizae 1g.
Extract the active component of medicinal raw material by medicinal raw material extracting method in embodiment 1, obtain the Chinese medicine composition that embodiment 2 treats gout.
Embodiment 3
The Chinese medicine composition of the treatment gout of the present embodiment is be prepared from by the medicinal raw material of following weight proportion: Folium Perillae 20g, Radix Salviae Miltiorrhizae 8g, Herb Gynostemmae Pentaphylli 6g, Rhizoma Tupistrae Chinensis 7g, Herba Lycopodii 6g, Radix Glycyrrhizae 3g.
Extract the active component of medicinal raw material by medicinal raw material extracting method in embodiment 1, obtain the Chinese medicine composition that embodiment 3 treats gout.
Comparative example
The Chinese medicine composition of the treatment gout of this comparative example is be prepared from by the medicinal raw material of following weight proportion: Folium Perillae 25g, Radix Salviae Miltiorrhizae 8g, Rhizoma Tupistrae Chinensis 6g, Herba Lycopodii 6g, Radix Glycyrrhizae 3g.
Extract the active component of medicinal raw material by medicinal raw material extracting method in embodiment 1, obtain the Chinese medicine composition of comparative example treatment gout.
Pharmacodynamics and toxicity test:
In order to the efficacy and saferry of proved invention medicine, inventors performed pharmacodynamics and toxicity test investigation.The research method adopted and result of the test as follows:
1, test material
(1) medicine and reagent:
According to the Chinese medicine composition of embodiment 1 prepared by embodiment 1;
According to the Chinese medicine composition of comparative example prepared by comparative example;
Colchicine: be Yunnan Plant Pharmaceutical Industry Co., Ltd.'s product.
(2) animal: Kunming mouse, is provided by Sichuan institute of antibiotics Experimental Animal Center.
2, test method and result
(1) on the impact of hyperuricemia Mouse Blood uric acid level
Get Kunming mouse 50, male and female are use all, and body weight 18 ~ 22g is divided into five groups at random, often organize 10, first group is normal saline group, and second group is drug study group of the present invention (8g raw medicinal herbs/kg), 3rd group is positive controls, and the 4th group is matched group 1, and the 5th group is model group.
Normal saline is gavaged by the dosage of 8g/kg to first group, second group gavages the Chinese medicine composition of the embodiment of the present invention 1 preparation by the dosage of 8g raw medicinal herbs/kg, 3rd group gavages colchicine by the drug dose of 0.1mg/kg, 4th group gavages Chinese medicine composition prepared by comparative example by the dosage of 8g raw medicinal herbs/kg, do not do any process for 5th group, every day 1 time, continuous 4d.
After last administration 1h, except normal saline group, all the other each group, namely second group to the 5th group, animal Intraperitoneal injection of hypoxanthine 1mg/kg, causes mice hyperuricemia, and normal saline group presses 1mg/kg injecting normal saline.0.5h after injection, plucks eyeball to each treated animal and gets blood, and the blood obtained after centrifugal 15min, is got serum and surveyed Level of Serum Uric Acid under the speed conditions of 3000r/min.Table 1 be each experimental group and matched group after treatment, the statistical result of blood uric acid measured value.
Table 1
Note: compare with model group:
*p<0.01; Compare with matched group 1:
▲ ▲p<0.01.
In table 1, it is 169 ± 32umol/l that drug study group of the present invention records Level of Serum Uric Acid: close with the Level of Serum Uric Acid 128 ± 27umol/l of normal saline group and the Level of Serum Uric Acid 152 ± 28umol/l of positive controls; Level of Serum Uric Acid 748 ± 103umol/l that relative model group records reduces about 580umol/l, and the statistical result of drug study group of the present invention is relative to model group P<0.01, has significant difference; The traditional Chinese medicine composition for treating gout that the present invention treats gout has good curative effect.
And in table 1, it is 248 ± 23umol/l that matched group 1 records Level of Serum Uric Acid, relative drug study group of the present invention records Level of Serum Uric Acid 169 ± 32umol/l and exceeds about 80umol/l.And the blood uric acid measured value of drug study group of the present invention is compared with the blood uric acid measured value P < 0.01 of matched group 1, has significant difference.Learn thus, 6 taste medicinal raw materials are by after described weight proportion combination, and have Synergistic function, can significantly improve the curative effect of Chinese medicine composition, lack any component, the curative effect of Chinese medicine composition all significantly declines.
In sum, the present invention treats the Chinese medicine composition of gout, and the short treating period for the treatment of gout, instant effect, administration can take effect for 4 days, evident in efficacy.Administration injected hypoxanthine after 4 days, and the blood uric acid measured value of drug study group of the present invention all can not occur significantly to raise phenomenon; 6 taste medicinal raw materials, by after described weight proportion combination, have Synergistic function, can significantly improve the curative effect of Chinese medicine composition.Lack any component, its curative effect all significantly declines, and as matched group 1, after injection hypoxanthine, the blood uric acid measured value recording the relative drug study group of the present invention of Level of Serum Uric Acid raises about 80umol/l.
Claims (10)
1., containing a Chinese medicine composition for the treatment gout of Herb Gynostemmae Pentaphylli, it is characterized in that: it is prepared from by the medicinal raw material of following weight proportion: Folium Perillae 15 ~ 35 parts, Radix Salviae Miltiorrhizae 3 ~ 15 parts, Herb Gynostemmae Pentaphylli 2 ~ 8 parts, Rhizoma Tupistrae Chinensis 3 ~ 8 parts, Herba Lycopodii 3 ~ 8 parts, 1 ~ 5 part, Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Folium Perillae is 20 ~ 30 parts.
3. the Chinese medicine composition for the treatment of gout according to claim 2, is characterized in that: part by weight shared by Folium Perillae is 25 parts.
4. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Radix Salviae Miltiorrhizae is 5 ~ 10 parts.
5. the Chinese medicine composition for the treatment of gout according to claim 4, is characterized in that: part by weight shared by Radix Salviae Miltiorrhizae is 8 parts.
6. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Herb Gynostemmae Pentaphylli is 4 ~ 7 parts.
7. the Chinese medicine composition for the treatment of gout according to claim 6, is characterized in that: part by weight shared by Herb Gynostemmae Pentaphylli is 5 parts.
8. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Rhizoma Tupistrae Chinensis is 5 ~ 7 parts.
9. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Herba Lycopodii is 5 ~ 7 parts.
10. the Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: part by weight shared by Radix Glycyrrhizae is 2 ~ 4 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410626212.0A CN104435567A (en) | 2014-11-07 | 2014-11-07 | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410626212.0A CN104435567A (en) | 2014-11-07 | 2014-11-07 | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104435567A true CN104435567A (en) | 2015-03-25 |
Family
ID=52882828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410626212.0A Pending CN104435567A (en) | 2014-11-07 | 2014-11-07 | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435567A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998762A (en) * | 2016-05-09 | 2016-10-12 | 张钊 | Fiveleaf gynostemma herb containing healthcare pharmaceutical composition for preventing hyperlipidemia, hypertension and hyperglycemia and gout |
| CN107875266A (en) * | 2017-11-28 | 2018-04-06 | 高大朋 | For treating the oral traditional Chinese medicine of gout and tophus |
| CN114931618A (en) * | 2022-02-23 | 2022-08-23 | 广州大医中医医院有限公司 | Traditional Chinese medicine composition for treating gout |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085169A (en) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | Traditional Chinese medicine for treating uric acid nephritis |
| CN102940709A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940747A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940750A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940695A (en) * | 2012-11-01 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN104095940A (en) * | 2014-08-06 | 2014-10-15 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicine composition for treating gout |
-
2014
- 2014-11-07 CN CN201410626212.0A patent/CN104435567A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085169A (en) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | Traditional Chinese medicine for treating uric acid nephritis |
| CN102940709A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940747A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940750A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN102940695A (en) * | 2012-11-01 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating gout |
| CN104095940A (en) * | 2014-08-06 | 2014-10-15 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicine composition for treating gout |
Non-Patent Citations (4)
| Title |
|---|
| 胡殿宇等主编: "《临床医学概论》", 31 January 2013 * |
| 赵铮蓉等: ""绞股蓝提取物的抗痛风活性部位筛选"", 《中华中医药学刊》 * |
| 陈东银等主编: "《痛风合理用药与食疗》", 31 August 2014 * |
| 黎莉 等: ""中草药来源的黄嘌呤氧化酶抑制剂的研究进展"", 《中药材》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998762A (en) * | 2016-05-09 | 2016-10-12 | 张钊 | Fiveleaf gynostemma herb containing healthcare pharmaceutical composition for preventing hyperlipidemia, hypertension and hyperglycemia and gout |
| CN107875266A (en) * | 2017-11-28 | 2018-04-06 | 高大朋 | For treating the oral traditional Chinese medicine of gout and tophus |
| CN114931618A (en) * | 2022-02-23 | 2022-08-23 | 广州大医中医医院有限公司 | Traditional Chinese medicine composition for treating gout |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN104436018A (en) | Medicine for treating tumors and preparation method thereof | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN104491236A (en) | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN103446445B (en) | Traditional Chinese medicine preparation for treating qi-yin deficiency-type chronic bronchitis and preparation method thereof | |
| CN105456818A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and being capable of treating insomnia and preparation method of traditional Chinese medicine composition | |
| CN104383486A (en) | Medicament for treating bronchitis of children | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN111358906B (en) | Traditional Chinese medicine composition suitable for exogenous diseases | |
| CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
| CN104337898B (en) | A kind of Chinese medicine composition of the treatment gout containing Semen Pruni | |
| CN104435079A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN104547859A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating chronic tracheitis | |
| CN104337909B (en) | A kind of Chinese medicine composition of the treatment gout containing Aspongopus | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN103845690A (en) | Medicament for treating geriatric depression | |
| CN104337889B (en) | A kind of Chinese medicine composition of the treatment gout containing Lumbricus | |
| CN104398564A (en) | Tripterygium wilfordii containing Chinese medicinal composition for treatment of gout | |
| CN105106674A (en) | Traditional Chinese medicine composition for treating senile skin pruritus and preparation method of composition | |
| CN104435141A (en) | Traditional Chinese medicine composition containing winged euonymus twig and used for treating diabetes | |
| CN104436017A (en) | Traditional Chinese medicine composition containing caulis akebiae for treating gout | |
| CN104547945A (en) | Traditional Chinese medicine preparation for treating scrofula and preparation method of traditional Chinese medicine preparation | |
| CN104666468A (en) | Pharmaceutical composition for treating hyperthyroidism and scrofula | |
| CN104288541A (en) | Chinese herbal preparation for treating stroke and sequelae of stroke, as well as preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |